GP1BB

From WikiMD's WELLNESSPEDIA

GP1BB is a gene in humans that encodes a protein known as platelet glycoprotein Ib beta chain. This protein is a part of the glycoprotein Ib-V-IX complex, which is a platelet surface membrane protein complex that plays a crucial role in the process of blood coagulation and platelet adhesion to the endothelium. Mutations in this gene have been associated with Bernard-Soulier syndrome, a rare disorder characterized by thrombocytopenia, giant platelets, and bleeding tendency.

Function[edit]

The GP1BB gene provides instructions for making a protein that is part of a complex known as the glycoprotein Ib-IX-V complex. This complex is found on the surface of platelets, which are blood cell fragments that play a crucial role in blood clotting. The glycoprotein Ib-IX-V complex binds to a protein called von Willebrand factor, which is necessary for platelets to adhere to the site of a blood vessel injury and form a clot, preventing excessive bleeding.

Clinical significance[edit]

Mutations in the GP1BB gene can lead to Bernard-Soulier syndrome, a rare disorder characterized by thrombocytopenia, giant platelets, and a bleeding tendency. This condition is caused by a reduced amount or absence of the glycoprotein Ib-IX-V complex on the surface of platelets, which impairs the ability of platelets to adhere to the site of a blood vessel injury and form a clot.

See also[edit]

References[edit]


External links[edit]

  • GP1BB at the National Center for Biotechnology Information


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.